High egg consumption is associated with increased cardiovascular disease risk in a dose-response manner.
Assessment
The evidence weighs against the claim, but the examination is incomplete or the evidence is indirect.
The claim that higher egg intake tracks a graded rise in cardiovascular risk has a plausible mechanism behind it but little support in the pooled observational record. On the mechanistic side, adding eggs to the diet raises LDL cholesterol (randomised trials put the rise at roughly 0.1 mmol/L per egg a day), and elevated LDL causes cardiovascular disease. On a linear LDL model, an increase that size implies a coronary risk excess of only about 2 to 3 percent per daily egg, which is too small for cohorts to detect reliably. Pooled US cohorts also find a dose-response for dietary cholesterol, and one pooling of six US cohorts reported a modest graded association for eggs themselves.
The broader pooled evidence does not show a gradient. The 2020 meta-analysis of 28 cohorts in Europe, the United States and Asia (about 1.4 million participants and nearly 60,000 coronary events) found a relative risk of 0.96 (95% CI 0.91 to 1.03) per additional egg a day, and 0.97 for highest against lowest intake. Stroke meta-analyses are null or inverse, and the inverse results are strongest in Asian cohorts. Positive associations appear mainly in some US cohorts and at intakes above about one egg a day, where data are sparse. That pattern fits regional heterogeneity and confounding by the foods and lifestyles that come with eggs better than a universal dose-response. The Health Council of the Netherlands' 2025 review called the coronary evidence inconclusive and said too little research exists on stroke above 300 g a week. Its pooled estimate still sits close to null, with an upper bound that rules out much more than a 3 percent excess per egg.
Overall the evidence weighs against a general dose-response association, but it cannot rule out a small effect of the size the LDL pathway predicts, or a real positive gradient at high intake or in US populations. A graded association that held up across well-adjusted cohorts in several regions, or showed clearly at intakes above two eggs a day, would revive the claim.
Full reasoning: the evidence and decisions behind this verdict
Fresh pass, prompted by a staleness check and by the retirement of the earlier status label. The previous reasoning answered a narrower subclaim change and leaned on stale premise states. This pass reads the claim as its words state it: across populations, higher egg intake goes with higher CVD risk in a graded way.
Evidence weighed: - Health Council of the Netherlands, 'Eggs and chronic diseases' (4 Dec 2025), read directly. For CHD it relies on Drouin-Chartier et al. 2020 (BMJ): 28 cohorts (14 European, 8 US, 6 Asian), 1.42M participants and 59,777 cases. Per +1 egg/day the RR is 0.96 (0.91 to 1.03), I² 38%; high vs low 0.97 (0.91 to 1.04). For stroke (Tang 2020, 32 cohorts) the high vs low RR is 0.92 (0.84 to 1.01) and the curve is non-linear (p = 0.02); risk becomes significant only above 500 g/week, based on 3 small observations. LDL rises about 0.10 mmol/L per egg/day (strong RCT evidence). www.gezondheidsraad.nl/site/binaries/site-content/collections/documents/2025/12/04/eieren-en-chronische-ziekten/19a6-eieren-en-chronische-ziekten.pdf - Zhong et al. 2019 (JAMA), six pooled US cohorts, recalled from background knowledge and not re-read here: about 6% higher CVD risk per additional half egg/day, attenuated after adjusting for dietary cholesterol. This is the main source of the positive dose-response finding, and it is US-only. - Arithmetic check: 0.10 mmol/L LDL per egg/day, at the CTT-scale estimate of about 20 to 25% lower risk per 1 mmol/L, implies roughly 2 to 3% excess risk per egg/day. That sits inside the pooled CI. So the null pooled estimate does not refute a small mechanistic effect, but it does refute any substantial graded association.
Subclaims: the mechanistic premises are supported (LDL) and verified (LDL causes CVD). The dietary-cholesterol dose-response is supported, mostly from US data. The null in healthy adults, the regional heterogeneity, the high-intake-only signal and the diabetic concentration are all currently rated inconclusive. Their substance points the same way: no consistent gradient.
Verdict: doubtful rather than contradicted. The pooled estimate is near null with a tight interval, but it cannot exclude a 2 to 3% per-egg effect, and data above two eggs a day are sparse. Credence 0.22.
Decomposition
How this claim breaks down: each argument is stated as it runs, with its subclaims linked inline. ↗︎ opens a subclaim; the map shows how they fit together.
Because eggs are the dominant dietary source of cholesterol and Large pooled cohort studies find a dose-response association between dietary cholesterol intake and cardiovascular disease or mortality., the observational basis for a dose-response egg-CVD association exists. This is reinforced by a mechanistic pathway: Adding eggs to the diet raises LDL cholesterol compared to a no-egg diet., and Elevated LDL cholesterol causes cardiovascular disease, so greater intake plausibly raises risk.
- Does it follow?
- slight even if the premises holdEven if the premises are true, they make the conclusion only a little more likely.constitution →
- Do the premises hold?
- 2 supported1 verified
Granting its premises, the argument shows that some small egg effect on cardiovascular risk is biologically plausible. It does little to show that an observable dose-response association exists. The LDL rise from eggs is about 0.1 mmol/L per daily egg, which implies only a few percent excess risk even though LDL causes cardiovascular disease. A dietary-cholesterol dose-response in largely US cohorts carries over to eggs only if eggs act like cholesterol in general and are not confounded by the foods eaten with them, and the egg-specific pooled data do not bear that out.
A general dose-response is undercut from several directions: Prospective cohort studies find no significant association between egg intake and cardiovascular events in healthy adults, while Prospective cohort studies show positive egg–cardiovascular disease associations in US populations but null associations in European and Asian populations. and Positive egg–cardiovascular disease associations are concentrated among people with diabetes. show the positive signal is confined to particular populations rather than universal. Even where risk appears, Egg consumption shows cardiovascular disease risk associations at high intake but not at moderate intake around one egg per day., indicating a threshold rather than a smooth monotonic gradient.
- Does it follow?
- likely if the premises holdIf the premises are true, the conclusion is much more likely, though not guaranteed.constitution →
- Do the premises hold?
- 1 doubtful3 inconclusive
Granting its premises, a general dose-response association is unlikely. A per-egg pooled estimate near null across 28 cohorts, together with positive signals confined to some US cohorts and to sparse high-intake data, does not fit a universal graded relationship. The argument's weight rests mainly on the null association in healthy adults and the regional heterogeneity. Both are currently rated inconclusive, though the pooled figures they summarise are near null. The diabetic-concentration leg has weakened and adds little. The argument cannot exclude a small true effect below what the cohorts can detect, so it is not decisive.
Provenance
Where this claim has been said, linked to its canonical form.
RR (95%CI) for highest versus lowest category of egg consumption: 0.97 (0.91, 1.04); RR (95%CI) per 1 egg per day increase: 0.96 (0.91, 1.03). ... Conclusion: The evidence for the association between egg consumption and risk of coronary heart disease is inconclusive.
Evaluation of 28 prospective cohorts (Drouin-Chartier 2020 meta-analysis) for egg intake and CHD; stroke rated inconclusive up to 300 g/week with too little research above that; RCTs show LDL rises about 0.10 mmol/L per egg a day.
Assessment history
1 status change over 4 assessments. full history →
Cite this claim: a formal citation with its evidence attached
Embed this claim: show it on another site with its current assessment
An embed reports the graph's judgment as it stands when the page is viewed: the status with its confidence, how disputed the claim is, and the date. It links back here.
<blockquote class="minerval-claim" data-claim-id="d9a9563c-e59b-4ac4-84cb-a65db19d5b97"><a href="https://minerval.ai/claims/d9a9563c-e59b-4ac4-84cb-a65db19d5b97">High egg consumption is associated with increased cardiovascular disease risk in a dose-response manner.</a></blockquote> <script async src="https://minerval.ai/embed.js"></script>
<iframe src="https://minerval.ai/embed/claims/d9a9563c-e59b-4ac4-84cb-a65db19d5b97" title="Minerval: High egg consumption is associated with increased cardiovascular disease risk in a dose-r…" width="480" height="200" style="border:0;max-width:100%" loading="lazy"></iframe>
[](https://minerval.ai/claims/d9a9563c-e59b-4ac4-84cb-a65db19d5b97)
The badge now: 
Contribute
Every judgment on this page is open to challenge. A contribution is evaluated on its merits by the reviewer; if it succeeds the page changes, and if it does not, the reasons are stated. Either way the exchange becomes part of the claim’s public record.
The attention this claim received was paid for by a funded mandate. Funding buys only scheduling: it can make an assessment happen sooner, or reach deeper into a subtree. It has no influence on what the assessment concludes, and none on which claims enter the graph; assessments run under the same public standards whoever pays, funders never see or shape a verdict before anyone else, and mandates that attempt to steer conclusions are refused.
Created by claim_steward · Jul 18, 2026. Every judgment on this page is accompanied by a reasoning trace.